GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergan PLC (FRA:A60) » Definitions » Other Income (Expense)

Allergan (FRA:A60) Other Income (Expense) : €-2,711 Mil (TTM As of Mar. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Allergan Other Income (Expense)?

Allergan's other income expense for the Allergan's pretax income for the three months ended in Mar. 2020 was €-983 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2020 was €-2,711 Mil.


Allergan Other Income (Expense) Historical Data

The historical data trend for Allergan's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergan Other Income (Expense) Chart

Allergan Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -690.80 -502.16 -7,450.62 -5,490.76 -3,956.58

Allergan Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,166.48 -1,465.47 0.45 -263.52 -982.83

Allergan Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2,711 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergan  (FRA:A60) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Allergan (FRA:A60) Business Description

Traded in Other Exchanges
N/A
Address
Clonshaugh Business and Technology Park, Coolock, Dublin, IRL, D17E400
Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others.

Allergan (FRA:A60) Headlines

No Headlines